260 related articles for article (PubMed ID: 15905975)
1. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.
Mechulam A; Cerutti M; Pugnière M; Missé D; Gajardo J; Roquet F; Robinson J; Veas F
J Mol Med (Berl); 2005 Jul; 83(7):542-52. PubMed ID: 15905975
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.
Liu S; Fan S; Sun Z
J Mol Model; 2003 Oct; 9(5):329-36. PubMed ID: 14517611
[TBL] [Abstract][Full Text] [Related]
3. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
[TBL] [Abstract][Full Text] [Related]
4. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
Martín J; LaBranche CC; González-Scarano F
J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
[TBL] [Abstract][Full Text] [Related]
5. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.
Cormier EG; Tran DN; Yukhayeva L; Olson WC; Dragic T
J Virol; 2001 Jun; 75(12):5541-9. PubMed ID: 11356961
[TBL] [Abstract][Full Text] [Related]
6. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
7. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120.
Rizzuto C; Sodroski J
AIDS Res Hum Retroviruses; 2000 May; 16(8):741-9. PubMed ID: 10826481
[TBL] [Abstract][Full Text] [Related]
8. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
9. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
[TBL] [Abstract][Full Text] [Related]
10. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.
Cormier EG; Persuh M; Thompson DA; Lin SW; Sakmar TP; Olson WC; Dragic T
Proc Natl Acad Sci U S A; 2000 May; 97(11):5762-7. PubMed ID: 10823934
[TBL] [Abstract][Full Text] [Related]
11. High-affinity binding of southern African HIV type 1 subtype C envelope protein, gp120, to the CCR5 coreceptor.
Fromme BJ; Coetsee M; Van Der Watt P; Chan MC; Sperling KM; Katz AA; Flanagan CA
AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1527-36. PubMed ID: 19018669
[TBL] [Abstract][Full Text] [Related]
12. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
Doranz BJ; Baik SS; Doms RW
J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
[TBL] [Abstract][Full Text] [Related]
13. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.
Wang WK; Dudek T; Zhao YJ; Brumblay HG; Essex M; Lee TH
Proc Natl Acad Sci U S A; 1998 May; 95(10):5740-5. PubMed ID: 9576954
[TBL] [Abstract][Full Text] [Related]
14. Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization.
Suphaphiphat P; Thitithanyanont A; Paca-Uccaralertkun S; Essex M; Lee TH
J Virol; 2003 Mar; 77(6):3832-7. PubMed ID: 12610158
[TBL] [Abstract][Full Text] [Related]
15. Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
Espy N; Pacheco B; Sodroski J
Virology; 2017 Aug; 508():90-107. PubMed ID: 28521215
[TBL] [Abstract][Full Text] [Related]
16. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.
Schnur E; Noah E; Ayzenshtat I; Sargsyan H; Inui T; Ding FX; Arshava B; Sagi Y; Kessler N; Levy R; Scherf T; Naider F; Anglister J
J Mol Biol; 2011 Jul; 410(5):778-97. PubMed ID: 21763489
[TBL] [Abstract][Full Text] [Related]
17. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.
Rizzuto CD; Wyatt R; Hernández-Ramos N; Sun Y; Kwong PD; Hendrickson WA; Sodroski J
Science; 1998 Jun; 280(5371):1949-53. PubMed ID: 9632396
[TBL] [Abstract][Full Text] [Related]
18. Peptidomimetic inhibitors targeting the CCR5-binding site on the human immunodeficiency virus type-1 gp120 glycoprotein complexed to CD4.
Seitz M; Rusert P; Moehle K; Trkola A; Robinson JA
Chem Commun (Camb); 2010 Nov; 46(41):7754-6. PubMed ID: 20830376
[TBL] [Abstract][Full Text] [Related]
19. Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip.
Koma T; Yokoyama M; Kotani O; Doi N; Nakanishi N; Okubo H; Adachi S; Adachi A; Sato H; Nomaguchi M
J Virol; 2021 Jun; 95(13):e0217720. PubMed ID: 33883222
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
Yang J; Liu CQ
Acta Pharmacol Sin; 2000 Jan; 21(1):29-34. PubMed ID: 11263244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]